Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/2/2025 | $13.00 | Market Perform → Outperform | Northland Capital |
| 8/5/2024 | Outperform → Market Perform | Northland Capital | |
| 11/21/2022 | $20.00 | Outperform | Northland Capital |
Signs General Bussan Co., Ltd. as exclusive distributor in Japan to drive growth of inTEST EMS Products in the underpenetrated market Establishes Prodigy Processing Solutions as preferred distributor of iTS Thermonics® Ultra-Low Temperature and Cryogenic Chillers to the cannabis and hemp processing industries inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor ("semi"), today announced the addition of two key distributor partners that provide expanded geographic reach and bri
Uniting Cutting-Edge Technologies to Revolutionize Cannabis and Hemp Processing MIAMI, Jan. 14, 2025 /PRNewswire/ -- Prodigy USA LLC, also known as Prodigy Processing Solutions, today proudly announced its worldwide partnership with inTEST Environmental Technologies, a division of inTEST Corporation (NYSE:INTT). Effective immediately, Prodigy will serve as strategic distribution partner for its inTEST Thermal Solutions (iTS) Thermonics® Ultra-Low Temperature and Cryogenic Chillers across the cannabis, hemp, biomedical, and pharmaceutical processing industries, specifically tailored for cannabinoid-related applications.
inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor ("semi"), today announced that Nick Grant, President & CEO, and Duncan Gilmour, Chief Financial Officer, will present and virtually host investor meetings at the Needham Growth Conference on Thursday, January 16, 2025. The Company presentation is scheduled to begin at 2:15 p.m. Eastern Time. A live audio webcast of the event with accompanying slides will be available at INTT Investor Relations. An archive of the presentation will
8-K - INTEST CORP (0001036262) (Filer)
SCHEDULE 13G/A - INTEST CORP (0001036262) (Subject)
10-Q - INTEST CORP (0001036262) (Filer)
4 - INTEST CORP (0001036262) (Issuer)
4 - INTEST CORP (0001036262) (Issuer)
inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor ("semi"), announced today the appointment of Michael Goodrich to the position of President, Process Technologies Division. Mr. Goodrich is a global technology leader with proven experience leading international cross-function teams in technology and manufacturing organizations. Nick Grant, President and CEO, commented, "Mike brings the skills and experience in operations, engineering sales and marketing, and importantly in coachi
inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor ("semi"), today announced that Michael Tanniru will join inTEST as President of the Environmental Technologies Division effective May 8, 2023. Nick Grant, President and CEO, commented, "Mike brings significant leadership experience to the inTEST executive team with over 22 years of proven success in the process automation, power generation, oil & gas, machine tool, and leak and function test instrumentation industries. Most recen
inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing in targeted markets, including automotive, defense/aerospace, industrial, life sciences, security, and semiconductor, today announced the appointment of Meghan Blount as Vice President of Human Resources. "Meghan is a multifaceted professional in human capital and brings broad expertise in talent management, staff development and continuous improvement to inTEST. I believe she will be instrumental in advancing our culture and a key partner in achieving our 5-Point Strategy," commented Nick Grant, inTEST President & CEO. "I have had the opportunity to work with Meg
Northland Capital upgraded inTEST Corp from Market Perform to Outperform and set a new price target of $13.00
Northland Capital downgraded inTEST Corp from Outperform to Market Perform
Northland Capital initiated coverage of inTEST Corp with a rating of Outperform and set a new price target of $20.00
SC 13G/A - INTEST CORP (0001036262) (Subject)
SC 13G/A - INTEST CORP (0001036262) (Subject)
SC 13G - INTEST CORP (0001036262) (Subject)
inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor ("semi"), announced it will release its third quarter 2024 financial results before the opening of financial markets on Friday, November 1, 2024. The Company will host a conference call and webcast that day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. Third Quarter 2024 Conference Call Friday, November 1, 2024 8:30 a.
inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor ("semi"), announced it will release its second quarter 2024 financial results before the opening of financial markets on Friday, August 2, 2024. The Company will host a conference call and webcast that day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. Second Quarter 2024 Conference Call Friday, August 2, 2024 8:30 a.
Sequentially first quarter revenue increased 7%, or $1.9 million, including $1.4 million in revenue from the Alfamation acquisition Compared with the prior-year period, overall sales declined while the acquisition and growth from diversified markets, specifically industrial and defense/aerospace, helped to offset the weakness in semiconductor sales Earnings per diluted share was $0.05 while adjusted earnings per diluted share1 was $0.10 Generated $2.1 million in cash from operations in the quarter; cash at March 31, 2024 was $27.3 million and reflects the $19 million in cash used for the Alfamation acquisition Adjusting full year revenue expectation to $140 million to $150 mill
4 - INTEST CORP (0001036262) (Issuer)
4 - INTEST CORP (0001036262) (Issuer)
4 - INTEST CORP (0001036262) (Issuer)